Literature DB >> 35351460

Effects of acid on bone.

David A Bushinsky1, Nancy S Krieger2.   

Abstract

The homeostatic regulation of a stable systemic pH is of critical importance for mammalian survival. During metabolic acidosis (a reduction in systemic pH caused by a primary decrease in serum bicarbonate concentration), as seen in clinical disorders such as the later stages of chronic kidney disease, renal tubular acidosis, or chronic diarrhea, bone buffers the accumulated acid; however, this homeostatic function of the skeleton occurs at the expense of the bone mineral content and leads to decreased bone quality. During short-term studies to model acute metabolic acidosis, there is initial physiochemical bone mineral dissolution, releasing carbonate and phosphate proton buffers into the extracellular fluid. In addition, there is net proton influx into the mineral with release of bone sodium and potassium. During long-term studies to model chronic metabolic acidosis, there is also inhibition of osteoblast activity, resulting in reduced bone formation, and an increase in osteoclast activity, resulting in increased bone resorption and release of calcium and anionic proton buffers. These physicochemical and cell-mediated bone responses to metabolic acidosis, in addition to an acidosis-induced increased urine calcium excretion, without a corresponding increase in intestinal calcium absorption, induce a net loss of body calcium that is almost certainly derived from the mineral stores of bone.
Copyright © 2022 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  bone; calcium; mineral metabolism

Mesh:

Substances:

Year:  2022        PMID: 35351460      PMCID: PMC9133222          DOI: 10.1016/j.kint.2022.02.032

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   18.998


  167 in total

Review 1.  Management of osteoporosis in CKD Stages 3 to 5.

Authors:  Patricia L Gordon; Lynda A Frassetto
Journal:  Am J Kidney Dis       Date:  2010-05       Impact factor: 8.860

Review 2.  Regulation and Effects of FGF23 in Chronic Kidney Disease.

Authors:  John Musgrove; Myles Wolf
Journal:  Annu Rev Physiol       Date:  2019-11-19       Impact factor: 19.318

3.  Proton-induced physicochemical calcium release from ceramic apatite disks.

Authors:  D A Bushinsky; N E Sessler; R E Glena; J D Featherstone
Journal:  J Bone Miner Res       Date:  1994-02       Impact factor: 6.741

4.  Metabolic alkalosis decreases bone calcium efflux by suppressing osteoclasts and stimulating osteoblasts.

Authors:  D A Bushinsky
Journal:  Am J Physiol       Date:  1996-07

5.  Urine citrate excretion identifies changes in acid retention as eGFR declines in patients with chronic kidney disease.

Authors:  Nimrit Goraya; Jan Simoni; Lauren N Sager; Abdullah Mamun; Nicolaos E Madias; Donald E Wesson
Journal:  Am J Physiol Renal Physiol       Date:  2019-06-19

6.  Convergent signaling by acidosis and receptor activator of NF-kappaB ligand (RANKL) on the calcium/calcineurin/NFAT pathway in osteoclasts.

Authors:  Svetlana V Komarova; Alexey Pereverzev; Jonathan W Shum; Stephen M Sims; S Jeffrey Dixon
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-04       Impact factor: 11.205

7.  Chemical and Biochemical Basis of Cell-Bone Matrix Interaction in Health and Disease.

Authors:  Xu Feng
Journal:  Curr Chem Biol       Date:  2009-05-01

8.  Cellular contribution to pH-mediated calcium flux in neonatal mouse calvariae.

Authors:  D A Bushinsky; J M Goldring; F L Coe
Journal:  Am J Physiol       Date:  1985-06

9.  Effect of chronic metabolic acidosis on vitamin D metabolism in humans.

Authors:  J A Kraut; E M Gordon; J C Ransom; R Horst; E Slatopolsky; J W Coburn; K Kurokawa
Journal:  Kidney Int       Date:  1983-11       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.